Globus Medical Acquires Synaptive Medical, Strengthening Its Position in Cranial Neurosurgery
Key Highlights
- ➤Globus Medical completed Synaptive Medical acquisition on August 4, 2026.
- ➤Synaptive adds surgical visualization, navigation, planning, and MRI technologies.
- ➤Acquisition deepens Globus Medical’s cranial neurosurgery presence and growth prospects.
- ➤Globus is prioritizing customer continuity while finalizing Synaptive’s long-term commercial strategy.
- ➤Combined solutions could integrate Synaptive technologies with Globus Medical’s Excelsius ecosystem.
Expert Statements
Keith Pfeil, President and Chief Executive Officer of Globus Medical
“This acquisition builds on the foundation we have established in cranial neurosurgery and accelerates our growth in this important market.”
Keith Pfeil, President and Chief Executive Officer of Globus Medical
“Synaptive brings proven surgical planning and visualization technology, as well as relationships with leading neurosurgical centers, and we see a clear opportunity to combine these solutions with our enabling technology expertise to serve more neurosurgeons and their patients.”
AUDUBON, Pa., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. a leading musculoskeletal technology company, today announced that it completed the acquisition of Synaptive Medical, deepening the Company's presence in cranial neurosurgery and positioning it for further growth in this market.
Synaptive Medical is a medical technology company focused on developing solutions for complex cranial procedures, with technologies spanning surgical visualization, navigation, surgical planning, and MRI. The acquisition completed on August 4, 2026, through a court-appointed receivership process, adds to Globus Medical's portfolio of enabling technologies for neurosurgery.
Get started
Create a free account to read the full story.